A Q2 2023 Earnings — Agilent Technologies, Inc. Revenue & Financial Results | Market Cap Arena

AAgilent Technologies, Inc.

$33B

Q2 2023 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$1.7B+6.8% YoY

Gross Profit

$924M53.8% margin

Operating Income

$383M22.3% margin

Net Income

$302M17.6% margin

EPS (Diluted)

$1.02

QoQ Revenue Growth

-2.2%

Cash Flow

Operating Cash Flow

$398M

Free Cash Flow

$341M

Stock-Based Comp.

$24M

Balance Sheet

Total Assets

$10.8B

Total Liabilities

$5.0B

Stockholders' Equity

$5.8B

Cash & Equivalents

$1.2B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.7B	$1.6B	+6.8%
Gross Profit	$924M	$861M	+7.3%
Operating Income	$383M	$360M	+6.4%
Net Income	$302M	$274M	+10.2%

Revenue Segments

Life Sciences and Applied Markets

$968M56%

Agilent CrossLab

$387M23%

Diagnostics and Genomics

$362M21%

Geographic Segments

Americas

$676M39%

Asia Pacific

$608M35%

Europe

$433M25%